Meeting
2014 ASCO Annual Meeting
Multiplex genomic profiling of non-small cell lung cancer patients enrolled in the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin (WJOG6611LTR).
Authors
Hiroshige Yoshioka
Department of Respiratory Medicine, Kurashiki Central Hospital, Kurashiki, Japan
Hiroshige Yoshioka , Isamu Okamoto , Kazuko Sakai , Satoshi Morita , Hiroyasu Kaneda , Koji Takeda , Tomonori Hirashima , Yoshihito Kogure , Tatsuo Kimura , Toshiaki Takahashi , Shinji Atagi , Takashi Seto , Toshiyuki Sawa , Masashi Yamamoto , Miyako Satouchi , Motoyasu Okuno , Seisuke Nagase , Kazuhiko Nakagawa , Yoichi Nakanishi , Kazuto Nishio
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 8095)
DOI
10.1200/jco.2014.32.15_suppl.8095
Abstract #
8095
Poster Bd #
276
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Molecular characterization of NF1-mutated NSCLC and clinical outcomes.
First Author: Christopher Gates
Poster
2018 ASCO Annual Meeting
Upfront next generation sequencing in NSCLC: A publicly funded perspective.
First Author: Kirstin Perdrizet
Poster
2013 ASCO Annual Meeting
Multiplexed genetic analysis of malignant pleural mesothelioma and the relationship to clinical outcome.
First Author: Takehito Shukuya
Poster
2023 ASCO Annual Meeting
LIBELULE: A randomized phase III study to evaluate the clinical relevance of early liquid biopsy (LB) in patients with suspicious metastatic lung cancer.
First Author: Aurélie Swalduz